A Multicentre Prospective Study to Investigate the Prevalence of Sexual Dysfunction and Quality of Life in Women with Breast Cancer receiving Aromatase Inhibitors
Not Applicable
- Conditions
- Sexual DysfunctionBreast CancerCancer - Breast
- Registration Number
- ACTRN12607000068460
- Lead Sponsor
- Professor Michael Friedlander
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- Female
- Target Recruitment
- 200
Inclusion Criteria
Primary breast cancer. Post-menopausal (no menstrual periods for at least 6 months). 6-8 weeks post chemotherapy Not receiving adjuvant anti-oestrogen therapy at time of study entry Fluent in English Willingness to complete questionnaire.
Exclusion Criteria
Diagnosis of metastatic breast cancer.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method